NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $983 | -9.3% | 22,213 | -0.3% | 0.01% | -11.1% |
| Q2 2023 | $1,084 | -2.9% | 22,279 | +10.8% | 0.01% | -10.0% |
| Q1 2023 | $1,116 | +27.3% | 20,099 | -7.9% | 0.01% | +25.0% |
| Q4 2022 | $877 | -99.9% | 21,821 | +13.1% | 0.01% | 0.0% |
| Q3 2022 | $846,000 | +25.7% | 19,301 | +1.7% | 0.01% | +33.3% |
| Q2 2022 | $673,000 | -13.3% | 18,979 | -0.5% | 0.01% | 0.0% |
| Q1 2022 | $776,000 | -76.2% | 19,077 | -45.4% | 0.01% | -50.0% |
| Q4 2021 | $3,260,000 | +83.2% | 34,908 | +118.7% | 0.01% | -20.0% |
| Q3 2021 | $1,779,000 | -1.5% | 15,960 | +0.3% | 0.02% | +7.1% |
| Q2 2021 | $1,806,000 | +69.1% | 15,906 | +51.3% | 0.01% | -65.0% |
| Q1 2021 | $1,068,000 | -6.6% | 10,514 | -8.5% | 0.04% | -7.0% |
| Q4 2020 | $1,144,000 | +48.0% | 11,493 | +7.4% | 0.04% | +26.5% |
| Q3 2020 | $773,000 | +42.9% | 10,702 | -1.4% | 0.03% | +36.0% |
| Q2 2020 | $541,000 | +65.4% | 10,853 | -1.0% | 0.02% | +212.5% |
| Q1 2020 | $327,000 | -11.6% | 10,963 | -0.1% | 0.01% | +14.3% |
| Q4 2019 | $370,000 | +14.6% | 10,977 | +11.4% | 0.01% | 0.0% |
| Q3 2019 | $323,000 | +17.0% | 9,856 | -1.5% | 0.01% | +16.7% |
| Q2 2019 | $276,000 | – | 10,006 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |